Document ID: BIS-2015-0025-0001
Agency: bis
Document Type: Rule
Title: Implementation of the Australia Group November 2013 Intersessional Decisions
Posted Date: 2015-06-16T04:00Z

[Federal Register Volume 80, Number 115 (Tuesday, June 16, 2015)]
[Rules and Regulations]
[Pages 34266-34274]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-14471]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Bureau of Industry and Security

15 CFR Parts 740, 742, 752 and 774

[Docket No. 141229999-4999-01]
RIN 0694-AG45

Implementation of the Australia Group (AG) November 2013 
Intersessional Decisions

AGENCY: Bureau of Industry and Security, Commerce.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Bureau of Industry and Security (BIS) publishes this final 
rule to amend the Export Administration Regulations (EAR) to implement 
the recommendations presented at the November 2013 Australia Group (AG) 
intersessional implementation meeting and later adopted pursuant to the 
AG silent approval procedure. Specifically, this rule amends the 
Commerce Control List (CCL) entry in the EAR that controls

[[Page 34267]]

certain human and zoonotic pathogens and toxins, and removes the CCL 
entry that controls certain animal pathogens to reflect the merger of 
two AG common control lists based on recommendations presented at the 
AG intersessional implementation meeting. As a result of these 
recommendations, the AG ``List of Animal Pathogens for Export Control'' 
was merged with the AG ``List of Biological Agents for Export 
Control,'' creating a single AG common control list for these items 
(i.e., the AG ``List of Human and Animal Pathogens and Toxins for 
Export Control''). The scope of the controls on these human and animal 
pathogens and toxins was not affected by the merger of the two lists 
into a single AG common control list. This rule also makes conforming 
amendments to other provisions in the EAR to reflect these changes.
    In addition, this rule amends the CCL entry that controls chemical 
manufacturing facilities and equipment to reflect changes to the AG 
``Control List of Dual-Use Chemical Manufacturing Facilities and 
Equipment and Related Technology and Software,'' based on the November 
2013 AG intersessional recommendation to revise controls on certain 
valves, casings (valve bodies) designed for such valves, and preformed 
casing liners designed for such valves. This rule also amends this CCL 
entry to add a Technical Note clarifying how the terms ``multi-seal'' 
and ``seal-less'' are used with respect to the controls on pumps. In a 
change unrelated to any revisions to the AG common control lists or 
guidelines, this rule also amends this CCL entry to authorize the use 
of License Exception LVS for specified shipments.
    This rule does not contain changes based on the understandings 
reached at the June 2014 AG Plenary meeting, because no amendments to 
the EAR were required as a result of these understandings.

DATES: This rule is effective June 16, 2015.

ADDRESSES: Send comments regarding this collection of information, 
including suggestions for reducing the burden, to Jasmeet Seehra, 
Office of Management and Budget (OMB), by email to 
Jasmeet_K._Seehra@omb.eop.gov, or by fax to (202) 395-7285; and to the 
Regulatory Policy Division, Bureau of Industry and Security, Department 
of Commerce, 14th Street & Pennsylvania Avenue NW., Room 2705, 
Washington, DC 20230.

FOR FURTHER INFORMATION CONTACT: Richard P. Duncan, Ph.D., Director, 
Chemical and Biological Controls Division, Office of Nonproliferation 
and Treaty Compliance, Bureau of Industry and Security, Telephone: 
(202) 482-3343, Email: Richard.Duncan@bis.doc.gov.

SUPPLEMENTARY INFORMATION: The Bureau of Industry and Security (BIS) is 
amending the Export Administration Regulations (EAR) to implement the 
recommendations presented at the Australia Group (AG) Intersessional 
meeting held in Budapest, Hungary, on November 18-22, 2013, and adopted 
pursuant to the AG silent approval procedure in January/February 2014. 
The AG is a multilateral forum consisting of 41 participating countries 
that maintain export controls on a list of chemicals, biological 
agents, and related equipment and technology that could be used in a 
chemical or biological weapons program. The AG periodically reviews 
items on its control list to enhance the effectiveness of participating 
governments' national controls and to achieve greater harmonization 
among these controls.

Merger of ECCN 1C352 With ECCN 1C351 (Human and Animal Pathogens and 
``Toxins'')

    The AG intersessional recommendations adopted in January 2014 
addressed the merger of the AG ``List of Animal Pathogens for Export 
Control'' with the AG ``List of Biological Agents for Export Control'' 
to create a single AG common control list for all of these pathogens 
and toxins (i.e., the AG ``List of Human and Animal Pathogens and 
Toxins for Export Control'').
    This final rule amends the EAR to reflect the merger of these two 
AG common control lists by removing ECCN 1C352 (animal pathogens) from 
the CCL and adding the pathogens previously controlled under ECCN 1C352 
to ECCN 1C351 (human and zoonotic pathogens and ``toxins''). The latter 
ECCN is renamed to indicate that it now controls both human and animal 
pathogens and ``toxins.'' This rule also renumbers the items in ECCN 
1C351.a, and certain items in ECCN 1C351.c to accommodate the addition 
to ECCN 1C351 of those items that were controlled under ECCN 1C352 
prior to the publication of this rule. The following table lists the 
viruses that are controlled under ECCN 1C351.a, as a result of the 
removal of ECCN 1C352 and the aforementioned amendments to ECCN 1C351, 
and indicates the previous and current CCL designations for each item.

------------------------------------------------------------------------
                                      Previous CCL        Current CCL
      AG-Controlled viruses            designation        designation
------------------------------------------------------------------------
African horse sickness virus.....  ECCN 1C352.a.17...  ECCN 1C351.a.1.
African swine fever virus........  ECCN 1C352.a.1....  ECCN 1C351.a.2.
Andes virus......................  ECCN 1C351.a.1....  ECCN 1C351.a.3.
Avian influenza virus............  ECCN 1C352.a.2....  ECCN 1C351.a.4.
Bluetongue virus.................  ECCN 1C352.a.3....  ECCN 1C351.a.5.
Chapare virus....................  ECCN 1C351.a.2....  ECCN 1C351.a.6.
Chikungunya virus................  ECCN 1C351.a.3....  ECCN 1C351.a.7.
Choclo virus.....................  ECCN 1C351.a.4....  ECCN 1C351.a.8.
Congo-Crimean haemorrhagic fever   ECCN 1C351.a.5....  ECCN 1C351.a.9.
 virus.
Dengue fever virus...............  ECCN 1C351.a.6....  ECCN 1C351.a.10.
Dobrava-Belgrade virus...........  ECCN 1C351.a.7....  ECCN 1C351.a.11.
Eastern equine encephalitis virus  ECCN 1C351.a.8....  ECCN 1C351.a.12.
Ebola virus......................  ECCN 1C351.a.9....  ECCN 1C351.a.13.
Foot and mouth disease virus.....  ECCN 1C352.a.4....  ECCN 1C351.a.14.
Goat pox virus...................  ECCN 1C352.a.5....  ECCN 1C351.a.15.
Guanarito virus..................  ECCN 1C351.a.10...  ECCN 1C351.a.16.
Hantaan virus....................  ECCN 1C351.a.11...  ECCN 1C351.a.17.
Hendra virus (Equine               ECCN 1C351.a.12...  ECCN 1C351.a.18.
 morbillivirus).
Herpes virus (Aujeszky's disease)  ECCN 1C352.a.6....  ECCN 1C351.a.19.
Hog cholera virus (syn.: swine     ECCN 1C352.a.7....  ECCN 1C351.a.20.
 fever virus).
Japanese encephalitis virus......  ECCN 1C351.a.13...  ECCN 1C351.a.21.
Junin virus......................  ECCN 1C351.a.14...  ECCN 1C351.a.22.
Kyasanur Forest virus............  ECCN 1C351.a.15...  ECCN 1C351.a.23.

[[Page 34268]]

 
Laguna Negra virus...............  ECCN 1C351.a.16...  ECCN 1C351.a.24.
Lassa fever virus................  ECCN 1C351.a.17...  ECCN 1C351.a.25.
Louping ill virus................  ECCN 1C351.a.18...  ECCN 1C351.a.26.
Lujo virus.......................  ECCN 1C351.a.19...  ECCN 1C351.a.27.
Lumpy skin disease virus.........  ECCN 1C352.a.16...  ECCN 1C351.a.28.
Lymphocytic choriomeningitis       ECCN 1C351.a.20...  ECCN 1C351.a.29.
 virus.
Machupo virus....................  ECCN 1C351.a.21...  ECCN 1C351.a.30.
Marburg virus....................  ECCN 1C351.a.22...  ECCN 1C351.a.31.
Monkey pox virus.................  ECCN 1C351.a.23...  ECCN 1C351.a.32.
Murray Valley encephalitis virus.  ECCN 1C351.a.24...  ECCN 1C351.a.33.
Newcastle disease virus..........  ECCN 1C352.a.9....  ECCN 1C351.a.34.
Nipah virus......................  ECCN 1C351.a.25...  ECCN 1C351.a.35.
Omsk haemorrhagic fever virus....  ECCN 1C351.a.26...  ECCN 1C351.a.36.
Oropouche virus..................  ECCN 1C351.a.27...  ECCN 1C351.a.37.
Peste des petits ruminants virus.  ECCN 1C352.a.10...  ECCN 1C351.a.38.
Porcine enterovirus type 9 (syn.:  ECCN 1C352.a.11...  ECCN 1C351.a.39.
 swine vesicular disease virus).
Powassan virus...................  ECCN 1C351.a.28...  ECCN 1C351.a.40.
Rabies virus and other members of  ECCN 1C352.a.8....  ECCN 1C351.a.41.
 the Lyssavirus genus.
Rift Valley fever virus..........  ECCN 1C351.a.29...  ECCN 1C351.a.42.
Rinderpest virus.................  ECCN 1C352.a.12...  ECCN 1C351.a.43.
Rocio virus......................  ECCN 1C351.a.30...  ECCN 1C351.a.44.
Sabia virus......................  ECCN 1C351.a.31...  ECCN 1C351.a.45.
Seoul virus......................  ECCN 1C351.a.32...  ECCN 1C351.a.46.
Sheep pox virus..................  ECCN 1C352.a.13...  ECCN 1C351.a.47.
Sin nombre virus.................  ECCN 1C351.a.33...  ECCN 1C351.a.48.
St. Louis encephalitis virus.....  ECCN 1C351.a.34...  ECCN 1C351.a.49.
Teschen disease virus............  ECCN 1C352.a.14...  ECCN 1C351.a.50.
Tick-borne encephalitis virus      ECCN 1C351.a.35...  ECCN 1C351.a.51.
 (Russian Spring-Summer
 encephalitis virus).
Variola virus....................  ECCN 1C351.a.36...  ECCN 1C351.a.52.
Venezuelan equine encephalitis     ECCN 1C351.a.37...  ECCN 1C351.a.53.
 virus.
Vesicular stomatitis virus.......  ECCN 1C352.a.15...  ECCN 1C351.a.54.
Western equine encephalitis virus  ECCN 1C351.a.38...  ECCN 1C351.a.55.
Yellow fever virus...............  ECCN 1C351.a.39...  ECCN 1C351.a.56.
------------------------------------------------------------------------

    The redesignations of, and additions to, the bacteria controlled 
under ECCN 1C351.c are indicated in the following table. The 
designations of the bacteria listed in ECCN 1C351.c.1 through .c.14 
were not affected by the amendments to ECCN 1C351 and the removal of 
ECCN 1C352.

------------------------------------------------------------------------
                                      Previous CCL        Current CCL
      AG-Controlled bacteria           designation        designation
------------------------------------------------------------------------
Mycoplasma capricolum subspecies   ECCN 1C352.b.1.b..  ECCN 1C351.c.15.
 capripneumoniae (``strain F38'').
Mycoplasma mycoides subspecies     ECCN 1C352.b.1.a..  ECCN 1C351.c.16.
 mycoides SC (small colony)
 (a.k.a. contagious bovine
 pleuropneumonia).
Rickettsia prowazekii............  ECCN 1C351.c.15...  ECCN 1C351.c.17.
Salmonella typhi.................  ECCN 1C351.c.16...  ECCN 1C351.c.18.
Shiga toxin producing Escherichia  ECCN 1C351.c.17...  ECCN 1C351.c.19.
 coli (STEC).
Shigella dysenteriae.............  ECCN 1C351.c.18...  ECCN 1C351.c.20.
Vibrio cholerae..................  ECCN 1C351.c.19...  ECCN 1C351.c.21.
Yersinia pestis..................  ECCN 1C351.c.20...  ECCN 1C351.c.22.
------------------------------------------------------------------------

Conforming Amendments

    This rule also makes a number of conforming amendments to other EAR 
provisions to reflect the removal of ECCN 1C352 and the merger of the 
animal pathogens previously controlled under this ECCN with the human 
pathogens and toxins controlled under ECCN 1C351.
    Specifically, this rule amends Section 740.20 (License Exception 
Strategic Trade Authorization (STA)) by removing two references to ECCN 
1C352 from paragraph (b)(2)(v), which excludes from STA eligibility 
certain items on the CCL that are subject to chemical/biological (CB) 
license requirements to destinations indicated under CB Column 1 on the 
Commerce Country Chart (Supplement No. 1 to part 738 of the EAR). This 
rule also removes the reference to ECCN 1C352 from Section 
742.2(a)(1)(i), which identifies the items on the CCL that require a 
license for CB reasons to destinations indicated under CB Column 1 on 
the Commerce Country Chart.
    In addition, this rule amends Supplement No. 1 to part 742 (Non-
proliferation of Chemical and Biological Weapons) to remove references 
to ECCN 1C352 from paragraph (3), paragraphs (9)(ii) and (9)(iii), and 
paragraph (12). This rule also amends Section 752.3 to remove the 
reference to ECCN 1C352 from paragraph (a)(2), which identifies items 
controlled for CB reasons that are excluded from eligibility for 
Special Comprehensive Licenses. None of these changes affect the 
application of the aforementioned EAR provisions to the items 
previously controlled under ECCN 1C352, because all of these items are 
now controlled under ECCN 1C351, which continues to be referenced by 
each of these EAR provisions.
    This rule also makes conforming amendments to ECCNs 1C353, 1C991, 
1E001, and 1E351 to reflect the removal of ECCN 1C352 and the merger of 
the animal pathogens previously controlled under this ECCN with the 
human

[[Page 34269]]

pathogens and toxins controlled under ECCN 1C351. Specifically, this 
rule amends the List of Items controlled section in ECCN 1C353 to 
remove references to ECCN 1C352 from: (1) The Related Controls 
paragraph; (2) paragraphs .a.1 and .b.1 of the ``Items'' paragraph; and 
(3) the introductory text and paragraph .b of Technical Note 3 to ECCN 
1C353. ECCN 1C991 is amended to remove the reference to ECCN 1C352 from 
paragraph .a of the ``Items'' paragraph under the List of Items 
Controlled section. The License Requirements section of ECCN 1E001 is 
amended by removing the reference to ECCN 1C352 from the ``Control(s)'' 
language for ``Country Chart--CB Column 1.'' In addition, this rule 
amends ECCN 1E351 to remove references to ECCN 1C352 from the ECCN 
heading and from the ``Control(s)'' language for ``Country Chart--CB 
Column 1'' in the License Requirements section of the ECCN. None of 
these changes affect the controls in ECCNs 1C353, 1C991, 1E001, and 
1E351 on items related to former ECCN 1C352, because each of these 
ECCNs continues to control items related to ECCN 1C351, which now 
includes all of the items that were controlled under ECCN 1C352 prior 
to the publication of this rule.

Amendments to ECCN 2B350 (Dual-Use Chemical Manufacturing Facilities 
and Equipment)

    The AG intersessional recommendations adopted in February 2014 made 
changes to the AG ``Control List of Dual-Use Chemical Manufacturing 
Facilities and Equipment and Related Technology and Software.'' This 
rule amends Export Control Classification Number (ECCN) 2B350 to 
reflect the AG intersessional changes to this AG common control list. 
Specifically, ECCN 2B350 (Chemical Manufacturing Facilities and 
Equipment) is amended by revising the controls in 2B350.g on valves, 
casings (valve bodies) designed for such valves, and preformed casing 
liners designed for such valves. Prior to the publication of this final 
rule, 2B350.g controlled valves with nominal sizes greater than 1.0 cm 
(\3/8\ in.), and casings (valve bodies) or preformed casing liners 
designed for such valves, in which all surfaces that come in direct 
contact with the chemical(s) being produced, processed, or contained 
are made from specified materials. These valves, casings, and preformed 
casing liners continue to be controlled under 2B350.g, but the controls 
have been expanded, to control valves, in addition to those described 
above, that have all of the following characteristics: (1) A nominal 
size equal to or greater than 2.54 cm (1 inch) and equal to or less 
than 10.16 cm (4 inches); (2) casings (valve bodies) or preformed 
casing liners in which all surfaces that come in direct contact with 
the chemical(s) being produced, processed, or contained are made from 
specified materials; and (3) a closure element designed to be 
interchangeable. These two categories of valves are now controlled 
under 2B350.g.1 and .g.2, respectively, while the casings (valve 
bodies) or preformed casing liners designed for such valves are 
controlled under 2B350.g.3.
    In addition, this rule adds a new Technical Note 1 to 2B350.g to 
indicate that all surfaces of the valves controlled by 2B350g.1, and 
the casings (valve bodies) and preformed casing liners controlled by 
2B350.g.3, that come in direct contact with the chemical(s) being 
produced, processed, or contained are controlled by 2B350.g if they are 
made from any of the following materials:
    a. Alloys with more than 25% nickel and 20% chromium by weight;
    b. Nickel or alloys with more than 40% nickel by weight;
    c. Fluoropolymers (polymeric or elastomeric materials with more 
than 35% fluorine by weight);
    d. Glass (including vitrified or enameled coating or glass lining);
    e. Tantalum or tantalum alloys;
    f. Titanium or titanium alloys;
    g. Zirconium or zirconium alloys;
    h. Niobium (columbium) or niobium alloys; or
    i. Ceramic materials, as follows:
    i.1. Silicon carbide with a purity of 80% or more by weight;
    i.2. Aluminum oxide (alumina) with a purity of 99.9% or more by 
weight; or
    i.3. Zirconium oxide (zirconia).
    The materials specified in new Technical Note 1 to 2B350.g are 
identical to those identified, prior to the publication of this rule, 
in ECCN 2B350.g.1 through g.9. The Technical Note to 2B350.g that 
defined ``nominal size,'' for purposes of 2B350.g, is now designated as 
Technical Note 2 to 2B350.g.
    The overall impact of the AG intersessional changes on ECCN 2B350.g 
was the addition of another category of valves under 2B350.g.2, 
together with casings (valve bodies) and preformed casing liners 
designed for such valves having the characteristics described in 
2B350.g.3. Although the casings (valve bodies) and preformed casing 
liners for valves described in 2B350.g.2 are controlled separately, 
under 2B350.g.3, the presence of these components in valves not 
controlled under 2B350.g.1 that have a nominal size equal to or greater 
than 2.54 cm (1 inch) and equal to or less than 10.16 cm (4 inches), 
and a closure element that is designed to be interchangeable, makes 
such valves subject to control under 2B350.g.2.
    This rule also amends ECCN 2B350 to reflect the adoption by the AG 
of the November 2013 intersessional recommendation concerning pumps 
described on the AG ``Control List of Dual-Use Chemical Manufacturing 
Facilities and Equipment and Related Technology and Software.'' 
Specifically, this rule adds a new Technical Note to ECCN 2B350.i to 
clarify how the terms ``multi-seal'' and ``seal-less'' are used with 
respect to the controls on pumps described in this ECCN. The new 
Technical Note explains that the term seals, as used in the ECCN 
2B350.i controls on pumps, refers to seals that come into direct 
contact with the chemical(s) being processed (or that are designed to 
do so) and that provide a sealing function where a rotary or 
reciprocating drive shaft passes through the pump body.

Conforming Change to ECCN 1C350 (Precursor Chemicals)

    In addition to the AG intersessional changes described above, this 
rule amends ECCN 1C350 (Precursor chemicals) by adding a Technical Note 
3 at the end of the License Requirements section of this ECCN. This new 
Technical Note is intended to provide guidance, consistent with the AG 
``List of Chemical Weapons Precursors,'' in determining whether a 
particular precursor chemical or mixture is controlled under ECCN 
1C350. Technical Note 3 states that the CAS numbers indicated in ECCN 
1C350 are intended to assist in identifying whether a particular 
precursor chemical or mixture is controlled under this ECCN, 
irrespective of nomenclature. However, this Technical Note also 
cautions that precursor chemicals of the same structural formula (e.g., 
hydrates) are controlled by ECCN 1C350, regardless of name or CAS 
number, and that CAS numbers cannot be used as unique identifiers in 
all situations because some forms of the listed precursor chemical have 
different CAS numbers, and mixtures containing a precursor chemical 
listed in ECCN 1C350 may also have different CAS numbers.

License Exception LVS Authorized for ECCN 2B350 Items

    In a change unrelated to any revisions to the AG common control 
lists or guidelines, this rule also amends ECCN 2B350 (Chemical 
Manufacturing Facilities and Equipment) to authorize

[[Page 34270]]

the use of License Exception LVS (shipments of limited value) for 
single shipments of $2,000 or less. This change is consistent with the 
requirements of Section 740.3 of the EAR, except that eligible 
destinations for ECCN 2B350 items under License Exception LVS are 
limited to those Country Group B destinations indicated in Supplement 
No. 1 to part 740 of the EAR that are not also included in Country 
Group D:3 (Chemical & Biological).

Clarification of License Exception RPL Requirements

    BIS has received a number of inquiries concerning the requirements 
of the License Exception RPL (servicing and replacement of parts and 
equipment) ``one-for-one replacement'' provisions with respect to 
commodities controlled under ECCN 2B350 on the CCL. In particular, 
exporters have requested clarification concerning the requirement in 
Section 740.10(a)(2)(iii) of the EAR that ``the parts, components, 
accessories, or attachments to be replaced must either be destroyed 
abroad or returned promptly to the person who supplied the 
replacements, or to a foreign firm that is under the effective control 
of that person.'' The major concern expressed, in this regard, is 
whether an item (i.e., a commodity in ECCN 2B350) would be considered 
to be ``destroyed,'' for purposes of this requirement, if that item 
were not repairable.
    BIS considers a commodity (e.g., a commodity controlled under ECCN 
2B350) to be ``destroyed,'' for purposes of the RPL requirement in 
Section 740.10(a)(2)(iii) of the EAR, if that commodity is: (1) No 
longer capable of functioning for the purpose for which it was designed 
(i.e., due to normal wear and tear, a defect, or damage); and (2) not 
capable of being repaired to function for the purpose for which it was 
designed. In addition, a commodity that is identified on the CCL will 
be considered to be ``destroyed'' only if that commodity no longer 
possesses the characteristics that made it subject to control by the 
ECCN under which it was classified prior to its being ``destroyed'' 
(i.e., the classification of the commodity must change and the 
resulting commodity may be designated as EAR99, provided that it is not 
enumerated or otherwise described in another ECCN on the CCL).
    This interpretation by BIS is consistent with, but broader in scope 
than, the treatment of certain ``scrap'' described in Interpretation #7 
under Section 770.2 of the EAR, which applies to specified items that 
are no longer capable of functioning for the purpose for which they 
were designed, or of being repaired to function for that purpose, 
because the items have been damaged (e.g., by means of mangling, 
crushing, or cutting) to such a degree that they have been rendered 
useless (i.e., beyond the possibility of restoration to their original 
identity and condition). The difference is that Interpretation #7 
addresses only a single method by which items can be ``destroyed'' 
(i.e., damage to the item), while BIS's interpretation of the term 
``destroyed,'' as used in RPL, also refers to the inability of an item 
to function (i.e., for the purpose for which it was designed,) as a 
result of normal wear and tear to the item or because of a defect in 
the item, coupled with the inability to repair the item to restore its 
functionality. In short, turning an item into ``scrap'' is only one 
means of ``destroying'' its functionality, for purposes of the EAR.
    BIS intends to publish a separate rule that will propose amendments 
to License Exception RPL and Interpretation #7 (see Section 770.2 of 
the EAR) in order to provide additional clarification concerning what 
is meant in the EAR when items are referred to as having been 
``destroyed.''

June 2014 AG Plenary Understandings

    This rule does not contain any changes based on the understandings 
reached at the June 2014 AG Plenary meeting, because no amendments to 
the EAR were required as a result of these understandings.

Effect of This Rule on the Scope of the CB Controls in the EAR

    The changes made by this rule only marginally affect the scope of 
the EAR controls on human and animal pathogens/toxins and chemical 
manufacturing facilities/equipment.
    Although the ECCN 2B350.g controls on valves, casings (valve 
bodies) designed for such valves, and preformed casing liners designed 
for such valves were expanded, the expanded controls apply only to a 
relatively small percentage of items not controlled under 2B350.g prior 
to the publication of this rule. Consequently, any increase in the 
number of license applications resulting from this change is not 
expected to be significant, when considered as a percentage of all such 
items. Furthermore, any increase in the number of license applications 
submitted to BIS, as a result of the amendments to ECCN 2B350.g, is 
expected to be offset by the amendment to ECCN 2B350 that authorizes 
the use of License Exception LVS for all items controlled by this ECCN, 
subject to the requirements described in Section 740.3 of the EAR and 
the specific limitations indicated in the LVS paragraph of this ECCN.
    In addition, the scope of the CCL-based CB controls on human and 
animal pathogens and toxins was not affected by the merger of the 
animal pathogens previously controlled under ECCN 1C352 with the human 
pathogens and toxins in ECCN 1C351 (i.e., no pathogens or toxins were 
either added to, or removed from, the CCL, nor were there any changes 
in the scope of the CB license requirements for any of these pathogens 
or toxins). Therefore, these changes are not expected to have a 
significant impact on the number of license applications that will have 
to be submitted for such items.
    The conforming amendments to Section 740.20(b)(2)(v), Section 
742.2(a)(1)(i), Supplement No. 1 to part 742 (i.e., paragraphs (3), 
(9)(ii), (9)(iii), and (12) of the Supplement) and Section 752.3(a)(2), 
as described above, did not have any effect on the application of these 
provisions to the items that were controlled under ECCN 1C352 prior to 
the publication of this rule. Although these EAR provisions no longer 
contain references to ECCN 1C352, they continue to reference ECCN 
1C351, which now includes the animal pathogens previously controlled 
under ECCN 1C352.
    The conforming amendments to ECCNs 1C353, 1C991, 1E001, and 1E351, 
as described above, also did not have any effect on the scope of the 
CCL-based CB controls on items related to human and animal pathogens 
and toxins (e.g., genetic elements, vaccines, and technology related to 
such pathogens and toxins). Although ECCNs 1C353, 1C991, 1E001, and 
1E351 no longer contain references to ECCN 1C352, they continue to 
reference ECCN 1C351, which now includes the animal pathogens that were 
controlled under ECCN 1C352 prior to the publication of this rule. For 
this reason, the removal of ECCN 1C352 by this rule did not affect 
either the scope of the items controlled under ECCN 1C353, 1C991, 
1E001, or 1E351 for CB reasons or the level of CB controls applicable 
to such items. Therefore, these conforming changes are not expected to 
have a significant impact on the number of license applications that 
will have to be submitted for such items.
    Although the Export Administration Act expired on August 20, 2001, 
the President, through Executive Order 13222 of August 17, 2001, 3 CFR, 
2001 Comp., p. 783 (2002), as amended by Executive Order 13637 of March 
8, 2013, 78 FR 16129 (March 13, 2013),

[[Page 34271]]

and as extended by the Notice of August 7, 2014, 79 FR 46959 (August 
11, 2014), has continued the Export Administration Regulations in 
effect under the International Emergency Economic Powers Act. BIS 
continues to carry out the provisions of the Export Administration Act, 
as appropriate and to the extent permitted by law, pursuant to 
Executive Order 13222 as amended by Executive Order 13637.

Rulemaking Requirements

    1. Executive Orders 13563 and 12866 direct agencies to assess all 
costs and benefits of available regulatory alternatives and, if 
regulation is necessary, to select regulatory approaches that maximize 
net benefits (including potential economic, environmental, public 
health and safety effects, distributive impacts, and equity). Executive 
Order 13563 emphasizes the importance of quantifying both costs and 
benefits, of reducing costs, of harmonizing rules, and of promoting 
flexibility. This rule has been designated a ``significant regulatory 
action,'' although not economically significant, under section 3(f) of 
Executive Order 12866. Accordingly, the rule has been reviewed by the 
Office of Management and Budget.
    2. Notwithstanding any other provision of law, no person is 
required to respond to, nor shall any person be subject to a penalty 
for failure to comply with, a collection of information subject to the 
requirements of the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et 
seq.) (PRA), unless that collection of information displays a currently 
valid Office of Management and Budget (OMB) Control Number. This rule 
contains a collection of information subject to the requirements of the 
PRA. This collection has been approved by OMB under Control Number 
0694-0088 (Multi-Purpose Application), which carries a burden hour 
estimate of 58 minutes to prepare and submit form BIS-748. Send 
comments regarding this burden estimate or any other aspect of this 
collection of information, including suggestions for reducing the 
burden, to Jasmeet Seehra, Office of Management and Budget (OMB), and 
to the Regulatory Policy Division, Bureau of Industry and Security, 
Department of Commerce, as indicated in the ADDRESSES section of this 
rule.
    3. This rule does not contain policies with Federalism implications 
as that term is defined in Executive Order 13132.
    4. The provisions of the Administrative Procedure Act (5 U.S.C. 
553) requiring notice of proposed rulemaking, the opportunity for 
public participation, and a delay in effective date, are inapplicable 
because this regulation involves a military and foreign affairs 
function of the United States (See 5 U.S.C. 553(a)(1)). Immediate 
implementation of these amendments is non-discretionary and fulfills 
the United States' international obligation to the Australia Group 
(AG). The AG contributes to international security and regional 
stability through the harmonization of export controls and seeks to 
ensure that exports do not contribute to the development of chemical 
and biological weapons. The AG consists of 41 member countries that act 
on a consensus basis and the amendments set forth in this rule 
implement changes made to the AG common control lists (as a result of 
the adoption of the recommendations made at the November 2013 AG 
intersessional meeting) and other changes that are necessary to ensure 
consistency with the controls maintained by the AG. Since the United 
States is a significant exporter of the items in this rule, immediate 
implementation of this provision is necessary for the AG to achieve its 
purpose. Any delay in implementation will create a disruption in the 
movement of affected items globally because of disharmony between 
export control measures implemented by AG members, resulting in tension 
between member countries. Export controls work best when all countries 
implement the same export controls in a timely and coordinated manner.
    Further, no other law requires that a notice of proposed rulemaking 
and an opportunity for public comment be given for this final rule. 
Because a notice of proposed rulemaking and an opportunity for public 
comment are not required to be given for this rule under the 
Administrative Procedure Act or by any other law, the analytical 
requirements of the Regulatory Flexibility Act (5 U.S.C. 601 et seq.) 
are not applicable. Therefore, this regulation is issued in final form.

List of Subjects

15 CFR Parts 740 and 752

    Administrative practice and procedure, Exports, Reporting and 
recordkeeping requirements.

15 CFR Part 742

    Administrative practice and procedure, Chemicals, Exports, Foreign 
trade, Reporting and recordkeeping requirements.

15 CFR Part 774

    Exports, Reporting and recordkeeping requirements.

    For the reasons stated in the preamble, parts 740, 742, 752 and 774 
of the Export Administration Regulations (15 CFR parts 730-774) are 
amended as follows:

PART 740--[AMENDED]

0
1. The authority citation for 15 CFR part 740 continues to read as 
follows:

    Authority: 50 U.S.C. app. 2401 et seq.; 50 U.S.C. 1701 et seq.; 
22 U.S.C. 7201 et seq.; E.O. 13026, 61 FR 58767, 3 CFR, 1996 Comp., 
p. 228; E.O. 13222, 66 FR 44025, 3 CFR, 2001 Comp., p. 783; Notice 
of August 7, 2014, 79 FR 46959 (August 11, 2014).

Sec.  740.20  [Amended]

0
2. In Sec.  740.20:
0
a. Remove ``1C352,'' where it appears, twice, in paragraph (b)(2)(v); 
and
0
b. Remove ``1C353, or'' and add in its place ``1C353 or'' in the 
parenthetical in paragraph (b)(2)(v).

PART 742--[AMENDED]

0
3. The authority citation for 15 CFR part 742 continues to read as 
follows:

    Authority: 50 U.S.C. app. 2401 et seq.; 50 U.S.C. 1701 et seq.; 
22 U.S.C. 3201 et seq.; 42 U.S.C. 2139a; 22 U.S.C. 7201 et seq.; 22 
U.S.C. 7210; Sec. 1503, Pub. L. 108-11, 117 Stat. 559; E.O. 12058, 
43 FR 20947, 3 CFR, 1978 Comp., p. 179; E.O. 12851, 58 FR 33181, 3 
CFR, 1993 Comp., p. 608; E.O. 12938, 59 FR 59099, 3 CFR, 1994 Comp., 
p. 950; E.O. 13026, 61 FR 58767, 3 CFR, 1996 Comp., p. 228; E.O. 
13222, 66 FR 44025, 3 CFR, 2001 Comp., p. 783; Presidential 
Determination 2003-23 of May 7, 2003, 68 FR 26459, May 16, 2003; 
Notice of August 7, 2014, 79 FR 46959 (August 11, 2014); Notice of 
November 7, 2014, 79 FR 67035 (November 12, 2014).

Sec.  742.2  [Amended]

0
4. In Sec.  742.2, remove ``1C352,'' where it appears in paragraph 
(a)(1)(i).

Supplement No. 1 to Part 742--[Amended]

0
5. In Supplement No. 1 to part 742, remove ``1C352,'' where it appears 
in paragraph (3), in paragraphs (9)(ii) and (9)(iii), and in paragraph 
(12).

PART 752--[AMENDED]

0
6. The authority citation for 15 CFR part 752 continues to read as 
follows:

    Authority: 50 U.S.C. app. 2401 et seq.; 50 U.S.C. 1701 et seq.; 
E.O. 13020, 61 FR 54079, 3 CFR, 1996 Comp., p. 219; E.O. 13222, 66 
FR 44025, 3 CFR, 2001 Comp., p. 783; Notice of August 7, 2014, 79 FR 
46959 (August 11, 2014).

[[Page 34272]]

Sec.  752.3  [Amended]

0
7. In Sec.  752.3, remove ``1C352,'' where it appears in paragraph 
(a)(2).

PART 774--[AMENDED]

0
8. The authority citation for 15 CFR part 774 continues to read as 
follows:

    Authority: 50 U.S.C. app. 2401 et seq.; 50 U.S.C. 1701 et seq.; 
10 U.S.C. 7420; 10 U.S.C. 7430(e); 22 U.S.C. 287c, 22 U.S.C. 3201 et 
seq.; 22 U.S.C. 6004; 30 U.S.C. 185(s), 185(u); 42 U.S.C. 2139a; 42 
U.S.C. 6212; 43 U.S.C. 1354; 15 U.S.C. 1824a; 50 U.S.C. app. 5; 22 
U.S.C. 7201 et seq.; 22 U.S.C. 7210; E.O. 13026, 61 FR 58767, 3 CFR, 
1996 Comp., p. 228; E.O. 13222, 66 FR 44025, 3 CFR, 2001 Comp., p. 
783; Notice of August 7, 2014, 79 FR 46959 (August 11, 2014).

0
9. In Supplement No. 1 to Part 774 (the Commerce Control List), 
Category 1--Special Materials and Related Equipment, Chemicals, 
``Microorganisms'' and ``Toxins,'' ECCN 1C350 is amended by adding a 
new Technical Note 3 at the end of the License Requirements section to 
read as follows:

Supplement No. 1 to Part 774--The Commerce Control List

* * * * *
1C350 Chemicals that may be used as precursors for toxic chemical 
agents (see List of Items Controlled).

License Requirements

* * * * *
Technical Notes: 1. * * *
    2. * * *
    3. Precursor chemicals in ECCN 1C350 are listed by name, 
Chemical Abstract Service (CAS) number and CWC Schedule (where 
applicable). Precursor chemicals of the same structural formula 
(e.g., hydrates) are controlled by ECCN 1C350, regardless of name or 
CAS number. CAS numbers are shown to assist in identifying whether a 
particular precursor chemical or mixture is controlled under ECCN 
1C350, irrespective of nomenclature. However, CAS numbers cannot be 
used as unique identifiers in all situations because some forms of 
the listed precursor chemical have different CAS numbers, and 
mixtures containing a precursor chemical listed in ECCN 1C350 may 
also have different CAS numbers.
* * * * *

0
10. In Supplement No. 1 to Part 774 (the Commerce Control List), 
Category 1--Special Materials and Related Equipment, Chemicals, 
``Microorganisms'' and ``Toxins,'' ECCN 1C351 is revised to read as 
follows:

1C351 Human and animal pathogens and ``toxins'', as follows (see 
List of Items Controlled).

License Requirements

Reason for Control: CB, CW, AT

 
                                            Country chart (See Supp. No.
                Control(s)                         1 to part 738)
 
CB applies to entire entry................  CB Column 1.
 

    CW applies to 1C351.d.11 and d.12 and a license is required for 
CW reasons for all destinations, including Canada, as follows: CW 
applies to 1C351.d.11 for ricin in the form of (1) Ricinus Communis 
AgglutininII (RCAII), also known as ricin D or 
Ricinus Communis LectinIII (RCLIII) and (2) 
Ricinus Communis LectinIV (RCLIV), also known 
as ricin E. CW applies to 1C351.d.12 for saxitoxin identified by 
C.A.S. #35523-89-8. See Sec.  742.18 of the EAR for licensing 
information pertaining to chemicals subject to restriction pursuant 
to the Chemical Weapons Convention (CWC). The Commerce Country Chart 
is not designed to determine licensing requirements for items 
controlled for CW reasons.

 
                                            Country chart (See Supp. No.
                Control(s)                         1 to part 738)
 
AT applies to entire entry................  AT Column 1.
 

    License Requirement Notes: 1. All vaccines and ``immunotoxins'' 
are excluded from the scope of this entry. Certain medical products 
and diagnostic and food testing kits that contain biological toxins 
controlled under paragraph (d) of this entry, with the exception of 
toxins controlled for CW reasons under d.11 and d.12, are excluded 
from the scope of this entry. Vaccines, ``immunotoxins'', certain 
medical products, and diagnostic and food testing kits excluded from 
the scope of this entry are controlled under ECCN 1C991.
    2. For the purposes of this entry, only saxitoxin is controlled 
under paragraph d.12; other members of the paralytic shellfish 
poison family (e.g., neosaxitoxin) are designated EAR99.
    3. Clostridium perfringens strains, other than the epsilon 
toxin-producing strains of Clostridium perfringens described in 
c.12, are excluded from the scope of this entry, since they may be 
used as positive control cultures for food testing and quality 
control.
    4. Unless specified elsewhere in this ECCN 1C351 (e.g., in 
License Requirement Notes 1-3), this ECCN controls all biological 
agents and ``toxins,'' regardless of quantity or attenuation, that 
are identified in the List of Items Controlled for this ECCN, 
including small quantities or attenuated strains of select 
biological agents or ``toxins'' that are excluded from the lists of 
select biological agents or ``toxins'' by the Animal and Plant 
Health Inspection Service (APHIS), U.S. Department of Agriculture, 
or the Centers for Disease Control and Prevention (CDC), U.S. 
Department of Health and Human Services, in accordance with their 
regulations in 9 CFR part 121 and 42 CFR part 73, respectively.

List Based License Exceptions (See Part 740 for a Description of All 
License Exceptions)

LVS: N/A
GBS: N/A
CIV: N/A

Special Conditions for STA

STA: (1) Paragraph (c)(1) of License Exception STA (Sec.  
740.20(c)(1)) may be used for items in 1C351.d.1 through 1C351.d.10 
and 1C351.d.13 through 1C351.d.19. See Sec.  740.20(b)(2)(vi) for 
restrictions on the quantity of any one toxin that may be exported 
in a single shipment and the number of shipments that may be made to 
any one end user in a single calendar year. Also see the Automated 
Export System (AES) requirements in Sec.  758.1(b)(4) of the EAR. 
(2) Paragraph (c)(2) of License Exception STA (Sec.  740.20(c)(2) of 
the EAR) may not be used for any items in 1C351.

List of Items Controlled

Related Controls: (1) Certain forms of ricin and saxitoxin in 
1C351.d.11. and d.12 are CWC Schedule 1 chemicals (see Sec.  742.18 
of the EAR). The U.S. Government must provide advance notification 
and annual reports to the OPCW of all exports of Schedule 1 
chemicals. See Sec.  745.1 of the EAR for notification procedures. 
See 22 CFR part 121, Category XIV and Sec.  121.7 for CWC Schedule 1 
chemicals that are ``subject to the ITAR.'' (2) The Animal and Plant 
Health Inspection Service (APHIS), U.S. Department of Agriculture, 
and the Centers for Disease Control and Prevention (CDC), U.S. 
Department of Health and Human Services, maintain controls on the 
possession, use, and transfer within the United States of certain 
items controlled by this ECCN (for APHIS, see 7 CFR 331.3(b), 9 CFR 
121.3(b), and 9 CFR 121.4(b); for CDC, see 42 CFR 73.3(b) and 42 CFR 
73.4(b)). (3) See 22 CFR part 121, Category XIV(b), for modified 
biological agents and biologically derived substances that are 
``subject to the ITAR.''
Related Definitions: (1) For the purposes of this entry 
``immunotoxin'' is defined as an antibody-toxin conjugate intended 
to destroy specific target cells (e.g., tumor cells) that bear 
antigens homologous to the antibody. (2) For the purposes of this 
entry ``subunit'' is defined as a portion of the ``toxin''.
Items:
    a. Viruses identified on the Australia Group (AG) ``List of 
Human and Animal Pathogens and Toxins for Export Control,'' as 
follows:
    a.1. African horse sickness virus;
    a.2. African swine fever virus;
    a.3. Andes virus;
    a.4. Avian influenza (AI) viruses identified as having high 
pathogenicity (HP), as follows:
    a.4.a. AI viruses that have an intravenous pathogenicity index 
(IVPI) in 6-week-old chickens greater than 1.2; or
    a.4.b. AI viruses that cause at least 75% mortality in 4- to 8-
week-old chickens infected intravenously.

    Note: Avian influenza (AI) viruses of the H5 or H7 subtype that 
do not have either of the characteristics described in 1C352.a.4 
(specifically, 1C352.a.4.a or a.4.b) should be sequenced to 
determine whether multiple basic amino acids are present at the 
cleavage site of the haemagglutinin molecule (HA0). If

[[Page 34273]]

the amino acid motif is similar to that observed for other HPAI 
isolates, then the isolate being tested should be considered as HPAI 
and the virus is controlled under 1C352.a.4.

    a.5. Bluetongue virus;
    a.6. Chapare virus;
    a.7. Chikungunya virus;
    a.8. Choclo virus;
    a.9. Congo-Crimean haemorrhagic fever virus (a.k.a. Crimean-
Congo haemorrhagic fever virus);
    a.10. Dengue fever virus;
    a.11. Dobrava-Belgrade virus;
    a.12. Eastern equine encephalitis virus;
    a.13. Ebola virus;
    a.14. Foot and mouth disease virus;
    a.15. Goat pox virus;
    a.16. Guanarito virus;
    a.17. Hantaan virus;
    a.18. Hendra virus (Equine morbillivirus);
    a.19. Herpes virus (Aujeszky's disease);
    a.20. Hog cholera virus (Swine fever virus);
    a.21. Japanese encephalitis virus;
    a.22. Junin virus;
    a.23. Kyasanur Forest virus;
    a.24. Laguna Negra virus;
    a.25. Lassa fever virus;
    a.26. Louping ill virus;
    a.27. Lujo virus;
    a.28. Lumpy skin disease virus;
    a.29. Lymphocytic choriomeningitis virus;
    a.30. Machupo virus;
    a.31. Marburg virus;
    a.32. Monkey pox virus;
    a.33. Murray Valley encephalitis virus;
    a.34. Newcastle disease virus;
    a.35. Nipah virus;
    a.36. Omsk haemorrhagic fever virus;
    a.37. Oropouche virus;
    a.38. Peste des petits ruminants virus;
    a.39. Porcine enterovirus type 9 (swine vesicular disease 
virus);
    a.40. Powassan virus;
    a.41. Rabies virus and all other members of the Lyssavirus 
genus;
    a.42. Rift Valley fever virus;
    a.43. Rinderpest virus;
    a.44. Rocio virus;
    a.45. Sabia virus;
    a.46. Seoul virus;
    a.47. Sheep pox virus;
    a.48. Sin nombre virus;
    a.49. St. Louis encephalitis virus;
    a.50. Teschen disease virus;
    a.51. Tick-borne encephalitis virus (Far Eastern subtype, 
formerly known as Russian Spring-Summer encephalitis virus--see 
1C351.b.3 for Siberian subtype);
    a.52. Variola virus;
    a.53. Venezuelan equine encephalitis virus;
    a.54. Vesicular stomatitis virus;
    a.55. Western equine encephalitis virus; or
    a.56. Yellow fever virus.
    b. Viruses identified on the APHIS/CDC ``select agents'' lists 
(see Related Controls paragraph #2 for this ECCN), but not 
identified on the Australia Group (AG) ``List of Human and Animal 
Pathogens and Toxins for Export Control,'' as follows:
    b.1. Reconstructed replication competent forms of the 1918 
pandemic influenza virus containing any portion of the coding 
regions of all eight gene segments;
    b.2. SARS-associated coronavirus (SARS-CoV); or
    b.3. Tick-borne encephalitis virus (Siberian subtype, formerly 
West Siberian virus--see 1C351.a.51 for Far Eastern subtype).
    c. Bacteria identified on the Australia Group (AG) ``List of 
Human and Animal Pathogens and Toxins for Export Control,'' as 
follows:
    c.1. Bacillus anthracis;
    c.2. Brucella abortus;
    c.3. Brucella melitensis;
    c.4. Brucella suis;
    c.5. Burkholderia mallei (Pseudomonas mallei);
    c.6. Burkholderia pseudomallei (Pseudomonas pseudomallei);
    c.7. Chlamydophila psittaci (formerly known as Chlamydia 
psittaci);
    c.8. Clostriduim argentinense (formerly known as Clostridium 
botulinum Type G), botulinum neurotoxin producing strains;
    c.9. Clostridium baratii, botulinum neurotoxin producing 
strains;
    c.10. Clostridium botulinum;
    c.11. Clostridium butyricum, botulinum neurotoxin producing 
strains;
    c.12. Clostridium perfringens, epsilon toxin producing types;
    c.13. Coxiella burnetii;
    c.14. Francisella tularensis;
    c.15. Mycoplasma capricolum subspecies capripneumoniae (``strain 
F38'');
    c.16. Mycoplasma mycoides subspecies mycoides SC (small colony) 
(a.k.a. contagious bovine pleuropneumonia);
    c.17. Rickettsia prowazekii;
    c.18. Salmonella typhi;
    c.19. Shiga toxin producing Escherichia coli (STEC) of 
serogroups O26, O45, O103, O104, O111, O121, O145, O157, and other 
shiga toxin producing serogroups;

    Note: Shiga toxin producing Escherichia coli (STEC) is also 
known as enterohaemorrhagic E. coli (EHEC) or verocytotoxin 
producing E. coli (VTEC).

    c.20. Shigella dysenteriae;
    c.21. Vibrio cholerae; or
    c.22. Yersinia pestis.
    d. ``Toxins'' identified on the Australia Group (AG) ``List of 
Human and Animal Pathogens and Toxins for Export Control,'' as 
follows, and ``subunits'' thereof:
    d.1. Abrin;
    d.2. Aflatoxins;
    d.3. Botulinum toxins;
    d.4. Cholera toxin;
    d.5. Clostridium perfringens alpha, beta 1, beta 2, epsilon and 
iota toxins;
    d.6. Conotoxin;
    d.7. Diacetoxyscirpenol toxin;
    d.8. HT-2 toxin;
    d.9. Microcystin (Cyanginosin);
    d.10. Modeccin toxin;
    d.11. Ricin;
    d.12. Saxitoxin;
    d.13. Shiga toxin;
    d.14. Staphylococcus aureus enterotoxins, hemolysin alpha toxin, 
and toxic shock syndrome toxin (formerly known as Staphylococcus 
enterotoxin F);
    d.15. T-2 toxin;
    d.16. Tetrodotoxin;
    d.17. Verotoxin and other Shiga-like ribosome inactivating 
proteins;
    d.18. Viscum Album Lectin 1 (Viscumin); or
    d.19. Volkensin toxin.
    e. ``Fungi'', as follows:
    e.1. Coccidioides immitis; or
    e.2. Coccidioides posadasii.

0
11. In Supplement No. 1 to Part 774 (the Commerce Control List), 
Category 1--Special Materials and Related Equipment, Chemicals, 
``Microorganisms'' and ``Toxins,'' ECCN 1C352 is removed.

0
12. In Supplement No. 1 to Part 774 (the Commerce Control List), 
Category 1--Special Materials and Related Equipment, Chemicals, 
``Microorganisms'' and ``Toxins,'' ECCN 1C353 is amended under the List 
of Items Controlled section:
0
a. By removing the phrase ``ECCN 1C351, 1C352, or 1C354'' and adding in 
its place the phrase ``ECCN 1C351 or 1C354'' in the first sentence of 
the ``Related Controls'' paragraph;
0
b. By removing the phrase ``1C351.a to .c, 1C352, or 1C354'' and adding 
in its place the phrase ``1C351.a to .c or 1C354'' in paragraph a.1 of 
the ``Items'' paragraph;
0
c. By removing the phrase ``1C351.a to .c, 1C352,'' and adding in its 
place the phrase ``1C351.a to .c or 1C354;'' in paragraph b.1 of the 
``Items'' paragraph; and
0
d. By removing the phrase ``1C351.a to .c 1C352, or 1C354'' and adding 
in its place the phrase ``1C351.a to .c or 1C354'' in the introductory 
text of Technical Note 3 and in paragraph b. of Technical Note 3.

0
13. In Supplement No. 1 to Part 774 (the Commerce Control List), 
Category 1--Special Materials and Related Equipment, Chemicals, 
``Microorganisms'' and ``Toxins,'' ECCN 1C991 is amended, under the 
``List of Items Controlled'' section, by removing the phrase ``ECCN 
1C351, 1C352, 1C353 or 1C354'' and adding in its place the phrase 
``ECCN 1C351, 1C353 or 1C354'' in paragraph a. of the ``Items'' 
paragraph.

0
14. In Supplement No. 1 to Part 774 (the Commerce Control List), 
Category 1--Special Materials and Related Equipment, Chemicals, 
``Microorganisms'' and ``Toxins,'' ECCN 1E001 is amended by revising 
the entry for ``Country Chart--CB Column 1'' in the License 
Requirements section to read as follows:

1E001 ``Technology'' according to the General Technology Note for 
the ``development'' or ``production'' of items controlled by 
1A001.b, 1A001.c, 1A002, 1A003, 1A004, 1A005, 1A006.b, 1A007, 1A008 
1A101, 1B (except 1B608, 1B613 or 1B999), or 1C (except 1C355, 
1C608, 1C980 to 1C984, 1C988, 1C990, 1C991, 1C995 to 1C999).

License Requirements

Reason for Control: NS, MT, NP, CB, RS, AT

[[Page 34274]]

 
                                            Country chart (see Supp. No.
                Control(s)                         1 to part 738)
 
 
                                * * * * *
CB applies to ``technology'' for items      CB Column 1.
 controlled by 1C351, 1C353, or 1C354.
 
                                * * * * *
 

* * * * *

0
15. In Supplement No. 1 to Part 774 (the Commerce Control List), 
Category 1--Special Materials and Related Equipment, Chemicals, 
``Microorganisms'' and ``Toxins,'' ECCN 1E351 is amended by revising 
the ECCN heading and by revising the entry for ``Country Chart--CB 
Column 1'' in the License Requirements section to read as follows:
1E351 ``Technology'' according to the General Technology Note for 
the disposal of chemicals or microbiological materials controlled by 
1C350, 1C351, 1C353, or 1C354.

License Requirements

Reason for Control: NS, MT, NP, CB, RS, AT

 
                                            Country chart (see Supp. No.
                Control(s)                         1 to part 738)
 
CB applies to ``technology'' for items      CB Column 1.
 controlled by 1C351, 1C353, or 1C354.
 
                                * * * * *
 

* * * * *

0
16. In Supplement No. 1 to Part 774 (the Commerce Control List), 
Category 2--Materials Processing, ECCN 2B350 is amended by revising the 
``LVS'' paragraph in the List Based License Exceptions section and 
also, under the List of Items Controlled section, by revising paragraph 
g. in the ``Items'' paragraph, by redesignating the Technical Note to 
2B350.g as Technical Note 2 to 2B350.g, by adding a Technical Note 1 to 
2B350.g immediately preceding Technical Note 2, and by adding a 
Technical Note to 2B350.i immediately following 2B350.i.11, to read as 
follows:

2B350 Chemical manufacturing facilities and equipment, except valves 
controlled by 2A226 or 2A292, as follows (see List of Items 
Controlled).
* * * * *

List Based License Exceptions (See Part 740 for a Description of All 
License Exceptions)

LVS: $2,000 for all Country Group B destinations, except those also 
listed under Country Group D:3 (see Supplement No. 1 to part 740 of 
the EAR).
GBS: * * *
CIV: * * *

List of Items Controlled

Related Controls: * * *
Related Definition: * * *
Items:
* * * * *
    g. Valves, as follows:
    g.1. Valves having both of the following characteristics:
    g.1.a. A nominal size greater than 1.0 cm (\3/8\ in.); and
    g.1.b. All surfaces that come in direct contact with the 
chemical(s) being produced, processed, or contained are made from 
materials identified in Technical Note 1 to 2B350.g.
    g.2. Valves, except for valves controlled by 2B350.g.1, having 
all of the following characteristics:
    g.2.a. A nominal size equal to or greater than 2.54 cm (1 inch) 
and equal to or less than 10.16 cm (4 inches);
    g.2.b. Casings (valve bodies) or preformed casing liners 
controlled by 2B350.g.3, in which all surfaces that come in direct 
contact with the chemical(s) being produced, processed, or contained 
are made from materials identified in Technical Note 1 to 2B350.g; 
and
    g.2.c. A closure element designed to be interchangeable.
    g.3. Casings (valve bodies) and preformed casing liners having 
both of the following characteristics:
    g.3.a. Designed for valves in 2B350.g.1 or .g.2; and
    g.3.b. All surfaces that come in direct contact with the 
chemical(s) being produced, processed, or contained are made from 
materials identified in Technical Note 1 to 2B350.g.

    Technical Note 1 to 2B350.g: All surfaces of the valves 
controlled by 2B350.g.1, and the casings (valve bodies) and 
preformed casing liners controlled by 2B350.g.3, that come in direct 
contact with the chemical(s) being produced, processed, or contained 
are made from the following materials:
    a. Alloys with more than 25% nickel and 20% chromium by weight;
    b. Nickel or alloys with more than 40% nickel by weight;
    c. Fluoropolymers (polymeric or elastomeric materials with more 
than 35% fluorine by weight);
    d. Glass (including vitrified or enameled coating or glass 
lining);
    e. Tantalum or tantalum alloys;
    f. Titanium or titanium alloys;
    g. Zirconium or zirconium alloys;
    h. Niobium (columbium) or niobium alloys; or
    i. Ceramic materials, as follows:
    i.1. Silicon carbide with a purity of 80% or more by weight;
    i.2. Aluminum oxide (alumina) with a purity of 99.9% or more by 
weight; or
    i.3. Zirconium oxide (zirconia).

* * * * *
    i. * * *

    Technical Note to 2B350.i: The seals referred to in 2B350.i come 
into direct contact with the chemical(s) being processed (or are 
designed to do so), and provide a sealing function where a rotary or 
reciprocating drive shaft passes through a pump body.

* * * * *

    Dated: June 9, 2015.
Kevin J. Wolf,
Assistant Secretary for Export Administration.
[FR Doc. 2015-14471 Filed 6-15-15; 8:45 am]
BILLING CODE 3510-33-P